{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Minneapolis",
      "state": "MN",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "67735",
      "recalling_firm": "Paddock Laboratories, LLC",
      "address_1": "3940 Quebec Ave N",
      "address_2": "",
      "postal_code": "55427-1244",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1168-2014",
      "product_description": "Perrigo, Clindamycin Palmitate Hydrochloride for Oral Solution, USP,  75mg/5mL, 100 ml, NDC 0574-0129-01",
      "product_quantity": "156,012 bottles",
      "reason_for_recall": "Presence of Particulate Matter Perrigo is recalling seven lots of Clindamycin Palmitate Hydrochloride for Oral Solution 75mg/5ml.",
      "recall_initiation_date": "20140311",
      "center_classification_date": "20140320",
      "termination_date": "20140918",
      "report_date": "20140326",
      "code_info": "2013313915 Exp 08/15, 2013374398 Exp 09/15, 2013323969 Exp 08/15, 2013364336 Exp 09/15, 2013323971 Exp 08/15, 2013364334 Exp 09/15, 2013313913 Exp 08/15",
      "more_code_info": ""
    }
  ]
}